Clinical Trial Update: A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005) [Phase 1]

View source ↗

Summary

Phase 1 study assessing how hepatic insufficiency affects the pharmacokinetics of vaniprevir (MK-7009-005) in Hepatitis C patients; results completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• vaniprevir (vaniprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED | Results posted: 2014-09-29